STRO
Sutro Biopharma Inc.
$29.63
-$0.06(-0.20%)
57
Overall
40
Value
90
Tech
42
Quality
Market Cap
$70.66M
Volume
188.76K
52W Range
$6.74 - $43.85
Target Price
$44.64
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Total Revenue | $38.4M | $42.7M | $42.7M | $61.9M | $67.8M | $153.7M | $62.0M | $102.5M | ||
| Total Revenue | $38.4M | $42.7M | $42.7M | $61.9M | $67.8M | $153.7M | $62.0M | $102.5M | ||
| GROSS PROFIT | ||||||||||
| Gross Profit | $38.4M | $42.7M | $42.7M | $61.9M | $67.8M | $153.7M | $62.0M | $102.5M | ||
| OPERATING EXPENSES | ||||||||||
| Operating Expenses | $-75.6M | $98.2M | $113.8M | $160.4M | $196.7M | $243.0M | $300.5M | $260.9M | ||
| Research & Development | $54.3M | $65.6M | $77.0M | $104.4M | $137.2M | $180.4M | $252.0M | $166.4M | ||
| Research Expense | $54.3M | $65.6M | $77.0M | $104.4M | $137.2M | $180.4M | $252.0M | $166.4M | ||
| Selling, General & Administrative | $21.4M | $32.6M | $36.8M | $56.0M | $59.5M | $62.6M | $48.5M | $41.0M | ||
| General & Administrative Expenses | $21.4M | $32.6M | $36.8M | $56.0M | $59.5M | $62.6M | $48.5M | $41.0M | ||
| Salaries & Wages | $-2.9M | -- | -- | -- | $26.3M | $24.9M | -- | -- | ||
| Depreciation & Amortization | -- | -- | $4.3M | $4.8M | $5.7M | $6.8M | $7.2M | -- | ||
| Depreciation & Amortization | -- | -- | $4.3M | $4.8M | $5.7M | $6.8M | -- | -- | ||
| Amortization | -- | $200.0K | $500.0K | $600.0K | $500.0K | $300.0K | -- | -- | ||
| Other Operating Expenses | $-741.0K | $-1.0M | $-1.1M | $-1.5M | $-2.3M | $-2.6M | $300.5M | $260.9M | ||
| OPERATING INCOME | ||||||||||
| Operating income | $-37.2M | $-55.5M | $-71.1M | $-98.5M | $-128.9M | $-89.3M | $-238.5M | $-158.4M | ||
| EBITDA | $-33.2M | $-47.0M | $-23.8M | $-97.6M | $-107.7M | $-81.8M | $-217.9M | $-183.9M | ||
| NON-OPERATING ITEMS | ||||||||||
| Interest Expense (Non-Operating) | $-1.6M | $1.1M | $4.0M | $3.1M | $3.3M | $23.8M | $31.1M | -- | ||
| Intinc | -- | -- | -- | -- | -- | $14.5M | $44.4M | -- | ||
| Net Non-Operating Interest Income/Expense | $1.6M | $-1.1M | $-2.3M | $-2.6M | $-109.0K | $-9.2M | $13.4M | -- | ||
| Gain on Sale of Securities | $1.6M | $4.1M | $1.5M | $577.0K | $3.5M | -- | $18.6M | $9.3M | ||
| Other Income/Expense | $-1.6M | $-4.1M | $-43.0M | $3.9M | $12.1M | $-24.4M | $-18.6M | $-9.3M | ||
| Other Special Charges | $1.9M | -- | $48.7M | -- | -- | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | $53.4M | ||
| Special Income Charges | -- | -- | -- | -- | -- | -- | -- | $-53.4M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | -- | $1.6M | ||
| PRE-TAX INCOME | ||||||||||
| EBIT | $-37.2M | $-50.3M | $-28.1M | $-102.4M | $-113.4M | $-88.6M | $-225.1M | $-191.2M | ||
| Pre-Tax Income | $-35.6M | $-51.4M | $-28.1M | $-105.5M | $-116.7M | $-88.6M | $-225.1M | $-191.2M | ||
| INCOME TAX | ||||||||||
| Tax Provision | -- | -- | $103.0K | -- | $2.5M | $18.2M | $2.4M | $-93.0K | ||
| NET INCOME | ||||||||||
| Net Income | $-35.3M | $-55.7M | $-32.1M | $-105.5M | $-119.2M | $-106.8M | $-227.5M | $-191.1M | ||
| Net Income (Continuing Operations) | $-35.3M | $-55.7M | $-32.1M | $-105.5M | $-119.2M | $-106.8M | $-227.5M | $-191.1M | ||
| Net Income (Discontinued Operations) | $-35.3M | $-55.7M | $-32.1M | $-105.5M | $-119.2M | $-106.8M | $-227.5M | $-191.1M | ||
| Net Income (Common Stockholders) | $-35.3M | $-55.7M | $-32.1M | $-105.5M | $-119.2M | $-106.8M | $-227.5M | $-191.1M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | $-136.3M | ||
| TOTALS | ||||||||||
| Total Expenses | $-75.6M | $98.2M | $113.8M | $160.4M | $196.7M | $243.0M | $300.5M | $260.9M | ||
| SHARE & EPS DATA | ||||||||||
| Average Shares Outstanding | $575.9K | $2.3M | $3.3M | $4.6M | $5.1M | $6.0M | $7.7M | $8.5M | ||
| Average Shares Outstanding (Diluted) | $674.5K | $2.3M | $3.3M | -- | $5.1M | $6.0M | $7.7M | $8.5M | ||
| Shares Outstanding | $2.3M | $2.3M | $4.6M | $4.6M | $6.0M | $6.2M | $8.4M | $16.6M | ||
| Basic EPS | -- | $-24.3 | $-9.9 | $-22.9 | $-23.5 | $-17.8 | $-29.6 | $-22.49 | ||
| Basic EPS (Continuing Operations) | -- | $-24.3 | $-9.9 | $-22.9 | $-23.5 | $-17.8 | $-29.6 | $-22.49 | ||
| Diluted EPS | $-61.3 | $-24.3 | $-9.9 | $-22.9 | $-23.5 | $-17.8 | $-29.6 | $-22.49 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-23.5 | $-17.8 | $-29.6 | $-22.49 | ||
| OTHER METRICS | ||||||||||
| Net Income From Other Gains Losses | $290.0K | $-4.3M | $-4.1M | $-3.1M | -- | -- | -- | -- | ||
| Other Gand A | $21.4M | $32.6M | $36.8M | $56.0M | $59.5M | $62.6M | $48.5M | $41.0M | ||
| Rent And Landing Fees | $21.4M | $3.6K | $4.7M | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | -- | $53.4M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STRO | $29.63 | -0.2% | 188.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |